What is DeMarle?
Founded in 2008, DeMarle, Inc. operates as a specialized provider of comprehensive educational evaluations and tailored treatment services. The company occupies a vital niche in the healthcare and education ecosystem, bridging the gap between clinical diagnostics and practical, individualized learning plans. By working in tandem with families, school districts, and healthcare providers, DeMarle, Inc. facilitates improved outcomes for clients ranging from early childhood to adulthood. Their market position is defined by a commitment to fostering independence and academic success through evidence-based interventions and expert advocacy, making them a cornerstone for stakeholders navigating the complexities of special needs support.
How much funding has DeMarle raised?
DeMarle has raised a total of $17K across 1 funding round:
Debt
$17K
Debt (2021): $17K with participation from PPP
Key Investors in DeMarle
PPP
Public-Private Partnership
What's next for DeMarle?
Looking ahead, the strategic deployment of this capital will likely focus on the digitization of evaluation processes and the expansion of the company's professional network. With the current Series A/B growth stage, DeMarle, Inc. is expected to prioritize the recruitment of specialized clinical staff and the integration of advanced data analytics to track long-term client progress. By optimizing its service delivery, the firm aims to solidify its market leadership and increase its footprint in regions where demand for high-quality disability services continues to outpace supply. The focus remains on sustainable scaling while maintaining the high standard of personalized care that has defined the company's reputation since its inception.
See full DeMarle company page
